AMINOSYN II 7% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 7% W/ ELECTROLYTES is a parenteral nutrition solution containing amino acids, electrolytes (magnesium, potassium, sodium), and phosphate for intravenous administration. It is indicated for patients requiring nutritional support who cannot obtain adequate nutrition through oral or enteral routes, such as post-operative patients, those with severe illness, or malabsorption disorders. The product provides essential amino acids and electrolyte balance to support protein synthesis and metabolic function.
LOE Approaching
As a mature, off-patent injectable product approaching loss of exclusivity, this brand faces moderate competitive pressure (30) with likely declining margins and smaller commercial teams focused on operational efficiency rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II offers stability in a mature, essential hospital product but limited upside for career advancement into innovation or brand-building roles. This is ideal for professionals seeking operational expertise, supply chain mastery, or hospital relationship management in a low-growth, commoditized segment.
Hospital Account ManagerSupply Chain Specialist
Worked on AMINOSYN II 7% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.